According to the diagnostic criteria for the patients included in the present study, we confirmed that several clinical parameters were altered in women with PCOS compared to women from the control group, such as androstenedione, estradiol, and testosterone serum levels, as well as the LH/FSH ratio, FAI, and IR-HOMA index (Table 1). This evidence concerns the gene PLOD1 and polycystic ovary syndrome.